KIMULIQUE HARKLEY ALLEN

Allopathic & Osteopathic Physicians|Internal Medicine DALLAS, TX NPI 1801836713

General Payments — all program years on this page

$3,253.07

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 220
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $319.87 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $319.8721

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $1,469.7598
2019 $1,463.45101
2020 $319.8721

Records — PY2020 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
718293659 Astellas Pharma US Inc $24.98 02/13/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719253289 Janssen Pharmaceuticals, Inc $17.08 01/07/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719253291 Janssen Pharmaceuticals, Inc $13.21 02/07/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719253293 Janssen Pharmaceuticals, Inc $11.02 02/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723734327 Allergan, Inc. $11.25 01/21/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
723734329 Allergan, Inc. $13.16 01/31/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
728519969 Lilly USA, LLC $11.32 03/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735743747 Arbor Pharmaceuticals, Inc. $14.77 01/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735743759 Arbor Pharmaceuticals, Inc. $12.70 03/05/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
735966273 AstraZeneca Pharmaceuticals LP $12.43 02/11/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736068109 AstraZeneca Pharmaceuticals LP $16.44 02/21/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736236139 AstraZeneca Pharmaceuticals LP $11.22 01/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
738522185 GlaxoSmithKline, LLC. $17.72 01/17/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
739956861 Amarin Pharma Inc. $16.51 02/06/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
741183489 Amgen Inc. $22.01 03/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
741183493 Amgen Inc. $22.60 01/23/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744177809 SANOFI-AVENTIS U.S. LLC $10.99 03/12/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744560075 Novo Nordisk Inc $12.49 01/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
746293521 Radius Health, Inc. $19.05 02/04/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747743205 Merck Sharp & Dohme Corporation $11.08 02/28/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
751425021 Antares Pharma, Inc. $17.84 01/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.